体温异常对严重脓毒症集束化治疗实施及结局的影响:聚焦急性呼吸窘迫综合征、脓毒症与创伤急诊救治结局研究的回顾性子分析
该研究为聚焦急性呼吸窘迫综合征、脓毒症与创伤急诊救治结局研究的回顾性子分析,纳入日本59个ICU的1143例严重脓毒症(Sepsis-2标准)成人患者,按入ICU时核心体温分为<36°C、36-38°C、>38°C三组。低体温(<36°C)占11.1%,该组患者年龄更大、BMI更低、脓毒性休克患病率更高,APACHE II和SOFA评分更高。低体温组3小时集束化治疗整体实施率及广谱抗生素给药率显著低于>38°C组;低体温组住院死亡率相对>38°C组的OR为1.760(95%CI 1.134-2.732)。低体温组无ICU天数和无呼吸机天数也显著更少。
要点
- 严重脓毒症患者入ICU时低体温(<36°C)占11.1%(127/1143),该组年龄更大、BMI更低、脓毒性休克患病率更高,APACHE II和SOFA评分更高。
- 低体温组住院死亡率相对体温>38°C组的OR为1.760(95%CI 1.134-2.732)。
- 低体温组3小时集束化治疗整体实施率及广谱抗生素给药率显著低于体温>38°C组。
- 低体温组无ICU天数和无呼吸机天数显著少于其他体温组。
- 三组间住院死亡率和28天死亡率差异显著。
适用人群与场景
- 日本59个ICU中,2016年1月至2017年3月收治的基于Sepsis-2标准诊断的严重脓毒症成人患者。
诊断标准与关键阈值
- 基于Sepsis-2标准诊断严重脓毒症。
- 按入ICU时核心体温分为三组:<36°C、36-38°C、>38°C。
研究设计与关键结果
- 研究类型:回顾性子分析;样本量1143例;日本59个ICU;人群为严重脓毒症成人患者;无干预。
- 低体温(<36°C)占11.1%(127例),36-38°C组565例,>38°C组451例。
- 低体温组较36-38°C或>38°C组年龄显著更大,BMI更低,脓毒性休克患病率高于>38°C组;入组当日APACHE II和SOFA评分显著更高。
- 3小时集束化治疗整体实施率及广谱抗生素给药率在三组间显著不同,低体温组显著低于>38°C组。
- 3小时复苏集束化治疗整体实施率+血管加压药使用+乳酸复测率在三组间显著不同。
- 住院死亡率和28天死亡率在三组间显著不同;低体温组相对>38°C组的住院死亡OR为1.760(95%CI 1.134-2.732)。
- 无ICU天数和无呼吸机天数在三组间显著不同,低体温组显著更少。
证据类型、等级与局限
- 证据类型:回顾性子分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为低体温与显著更高的疾病严重度、死亡风险及更低的脓毒症集束化治疗实施率相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the impact of body temperature on disease severity, implementation of sepsis bundles, and outcomes in severe sepsis patients.
DESIGN: Retrospective sub-analysis.
SETTING: Fifty-nine ICUs in Japan, from January 2016 to March 2017.
PATIENTS: Adult patients with severe sepsis based on Sepsis-2 were enrolled and divided into three categories (body temperature < 36°C, 36-38°C, > 38°C), using the core body temperature at ICU admission.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Compliance with the bundles proposed in the Surviving Sepsis Campaign Guidelines 2012, in-hospital mortality, disposition after discharge, and the number of ICU and ventilator-free days were evaluated. Of 1,143 enrolled patients, 127, 565, and 451 were categorized as having body temperature less than 36°C, 36-38°C, and greater than 38°C, respectively. Hypothermia-body temperature less than 36°C-was observed in 11.1% of patients. Patients with hypothermia were significantly older than those with a body temperature of 36-38°C or greater than 38°C and had a lower body mass index and higher prevalence of septic shock than those with body temperature greater than 38°C. Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores on the day of enrollment were also significantly higher in hypothermia patients. Implementation rates of the entire 3-hour bundle and administration of broad-spectrum antibiotics significantly differed across categories; implementation rates were significantly lower in patients with body temperature less than 36°C than in those with body temperature greater than 38°C. Implementation rate of the entire 3-hour resuscitation bundle + vasopressor use + remeasured lactate significantly differed across categories, as did the in-hospital and 28-day mortality. The odds ratio for in-hospital mortality relative to the reference range of body temperature greater than 38°C was 1.760 (95% CI, 1.134-2.732) in the group with hypothermia. The proportions of ICU-free and ventilator-free days also significantly differed between categories and were significantly smaller in patients with hypothermia.
CONCLUSIONS: Hypothermia was associated with a significantly higher disease severity, mortality risk, and lower implementation of sepsis bundles.
参考来源
- Kushimoto S, Abe T, Ogura H, et al. Impact of Body Temperature Abnormalities on the Implementation of Sepsis Bundles and Outcomes in Patients With Severe Sepsis: A Retrospective Sub-Analysis of the Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, Sepsis and Trauma Study. Crit Care Med. 2019. PMID: 30789402. doi:10.1097/CCM.0000000000003688
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。